We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$39.8M
2
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$32.6M
3
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$28.3M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$23.1M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$19.9M

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXE icon
1551
NexGen Energy
NXE
$6.17B
$117K 0.01%
+10,101
New +$121K
PROP icon
1552
Prairie Operating Co
PROP
$71.8M
$117K 0.01%
57,620
-289,134
-83% -$522K
IFRX icon
1553
InflaRx
IFRX
$250M
$114K 0.01%
+127,469
New +$120K
XRX icon
1554
Xerox
XRX
$357M
$113K 0.01%
+87,840
New +$174K
HURA
1555
TuHURA Biosciences
HURA
$141M
$112K 0.01%
+62,538
New +$76.6K
VZLA
1556
Vizsla Silver
VZLA
$1.17B
$109K 0.01%
+33,069
New +$151K
HNNA icon
1557
Hennessy Advisors
HNNA
$77.8M
$108K 0.01%
11,077
– –
MGTX icon
1558
MeiraGTx Holdings
MGTX
$1.14B
$108K 0.01%
+12,526
New +$95.1K
PAYO icon
1559
Payoneer
PAYO
$2.41B
$108K 0.01%
22,452
-229,526
-91% -$1.21M
BOLD
1560
Boundless Bio
BOLD
$55.7M
$107K 0.01%
96,824
+34,348
+55% +$40.2K
AARD
1561
Aardvark Therapeutics
AARD
$146M
$102K 0.01%
27,085
-8,839
-25% -$91.6K
ANVS icon
1562
Annovis Bio
ANVS
$71M
$101K 0.01%
+45,423
New +$125K
DWSN icon
1563
Dawson Geophysical
DWSN
$149M
$101K 0.01%
+29,230
New +$80.9K
GAIA icon
1564
Gaia
GAIA
$48.1M
$97K 0.01%
+35,165
New +$116K
EBS icon
1565
Emergent Biosolutions
EBS
$378M
$92K 0.01%
+11,113
New +$115K
OKUR
1566
OnKure Therapeutics
OKUR
$164M
$92K 0.01%
22,224
-23,724
-52% -$73.2K
VNCE icon
1567
Vince Holding Corp
VNCE
$77.7M
$91K 0.01%
37,731
+20,729
+122% +$56.9K
CTMX icon
1568
CytomX Therapeutics
CTMX
$708M
$90K 0.01%
19,140
-62,746
-77% -$318K
FGBI icon
1569
First Guaranty Bancshares
FGBI
$154M
$88K 0.01%
+10,794
New +$90.8K
WB icon
1570
Weibo
WB
$1.92B
$88K 0.01%
+10,057
New +$101K
VOC icon
1571
VOC Energy
VOC
$57M
$85K 0.01%
24,621
+2,757
+13% +$8.76K
APVO icon
1572
Aptevo Therapeutics
APVO
$5.25M
$84K 0.01%
+19,638
New +$134K
HRTX icon
1573
Heron Therapeutics
HRTX
$86.9M
$84K 0.01%
105,064
-30,025
-22% -$34.8K
GROV icon
1574
Grove Collaborative
GROV
$45.8M
$83K 0.01%
64,455
+4,970
+8% +$6.77K
HNST icon
1575
The Honest Company
HNST
$423M
$83K 0.01%
28,398
-5,700
-17% -$14.7K
61 62
63
64 65

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.